Qidwai, T: Drug Repurposing Against SARS-CoV-2. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Amazon Digital Services LLC - Kdp, 2023
- Softcover
- Neu
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in mit 5 Sternen
AbeBooks-Verkäufer/-in seit 14. August 2006
Nicht verfügbar
Softcover
Zustand: Neu
EUR 91,33
Artikelbeschreibung des Verkäufers
Neuware - Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking.
Bestandsnummer des Verkäufers 9789815123210
- Titel
- Qidwai, T: Drug Repurposing Against SARS-CoV-2
- Autor
- Tabish Qidwai
- Verlag
- Amazon Digital Services LLC - Kdp
- Erscheinungsjahr
- 2023
- Zustand
- Neu
- Einband
- Taschenbuch
- Sprache
- Englisch
- ISBN-10
- 9815123211
- ISBN-13
- 9789815123210
- Artikelgewicht
- 503 Gramm
- Abmessungen
- 254x178x14 mm
Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking.
Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource.
Key features
• An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19.
• How to use repurposing of available drugs for disease therapy.
• Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways.
• Provides references for further reading
Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource.
Key features
• An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19.
• How to use repurposing of available drugs for disease therapy.
• Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways.
• Provides references for further reading
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.